knowledge -WSS

knowledge

author：knowledge 2025-09-27 22:46:24 - browse：5

Since the pandemic, patients have become increasingly comfortable with getting their medications online. Direct-to-consumer telehealth has made it easy to schedule a virtual visit and get a script, sometimes within minutes, with prescriptions shipped to your doorstep.

Now, Big Pharma is ready to get in on the action.

In early January, Eli Lilly announced a platform that allows patients to access and fill prescriptions for its drugs online, timing the news to the availability of its obesity medication Zepbound. Using LillyDirect, patients click into a pipeline for their condition — obesity, diabetes, or migraine — and are routed to telehealth sites that can prescribe them one of Lilly’s drugs if they’re eligible. An integration with online pharmacy Truepill will deliver the meds.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： The cancer drug shortage isn’t new — and neither are the solutions
Next article： Ebola vaccine can save some who are already sick, per new study

WSS

Eli Lilly reports tirzepatide MASH success during Q4 earnings

Resistance to opioid

Tome Biosciences co

Eli Lilly reports tirzepatide MASH success during Q4 earnings

Here’s what’s in the FDA plan to include pregnant women in clinical trials

Sanofi seeks simpler, safer CRISPR sickle cell cure

knowledge

knowledge

hotspot

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Bernie Sanders gets little from pharma CEOs on drug prices

Alkermes shareholders re

Readout Newsletter: Replicate, Biogen's Leqembi, and Humira

Alkermes shareholders re

Whistleblower: Blue Cross Blue Shield evaded $170 million in taxes

Walensky prepares to leave CDC — and Congress — behind

Custom gene therapy hints at new path for rare disease treatments

BioMarin wins approval for gene therapy to treat hemophilia A

Abbott's new heart device gets FDA advisory panel nod

leisure time

Group opposing PBM reform sets lobbying record

At Orexo, a ‘turning point’ for everything but digital health

Why hospitals are withdrawing from US News rankings

AI can’t replace a physician’s gut feeling

Congress considering partial increase for doctor pay in Medicare

Cosmetics set for new safety regulation. Why the industry is on board

hotspot

focus

leisure time

Wikipedia